Liquidia, UNC announce new nanoparticle process

June 22, 2005 — Liquidia Technologies Inc. of Research Triangle Park, N.C., and The University of North Carolina at Chapel Hill announced a new process to create nanoparticles for delivering drugs and biological materials into the human body.

The technology, Particle Replication In Nonwetting Templates (PRINT) enables fabrication of custom-sized, monodispersed and shape-specific particles, according to a news release. The company says it works with virtually any material, including delicate substances, biological agents and small molecules, which can then be delivered through a full range of injectable, pulmonary, topical and oral methods.

A report on the findings appeared in the Journal of the American Chemical Society on Tuesday. Liquidia Technologies has an exclusive license from the University of North Carolina at Chapel Hill and North Carolina State University for the development and commercialization of the processes.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.